Evidence map›Paper›PMID 42680213›Full record

ArticleJournal of Korean biological nursing science2026

Association between cumulative biological risk and hypertension in older adults in Korea: a population-based cross-sectional study.

Hyemin Hwang, Kyeongmin Jang

Abstract read
In one paragraph

Article in Journal of Korean biological nursing science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hyemin HwangDepartment of Nursing, Bucheon University, Bucheon, Korea.
Kyeongmin JangDepartment of Nursing, College of Health Sciences, Daejin University, Pocheon, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study examined the association between cumulative biological risk and hypertension among older adults in Korea using nationally representative data.

methodsData were obtained from the 2024 Korea National Health and Nutrition Examination Survey, the most recent dataset released in December 2025. The main analytic sample included 1,551 adults aged 65 years or older. The cumulative biological risk score (CBRS) was calculated using five indicators: anemia, elevated glycated hemoglobin, obesity defined as body mass index ≥ 25 kg/m², elevated high-sensitivity C-reactive protein, and vitamin D deficiency. Hypertension was defined as self-reported physician-diagnosed hypertension. Complex sample analyses incorporated sampling weights, stratification variables, and cluster variables. Complex sample logistic regression was performed using IBM SPSS Statistics version 30.0.

resultsCBRS showed a graded association with hypertension across risk categories. Compared with the low-risk group, the moderate-risk group had higher odds of hypertension (odds ratio [OR] = 1.67, 95% confidence interval [CI]: 1.16-2.40), and the high-risk group had still higher odds (OR = 2.92, 95% CI: 1.87-4.54). Age, monthly alcohol use, and absence of aerobic physical activity were also associated with higher odds of hypertension.

conclusionCumulative biological risk was significantly associated with hypertension among older adults in Korea, suggesting that hypertension in later life may be related to accumulated biological dysregulation. An integrated assessment of multiple biological and metabolic abnormalities may help characterize clustered biological vulnerability and support comprehensive preventive nursing care.

Indexed as

AgedBiomarkersHypertensionInflammationRisk factors

Identifiers

PMID42680213
PMCPMC13533612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.